Active Pharmaceutical Ingredients Market Is Anticipated To Grow Due To High Capitalization For Development Of Novel DrugsTill 2025:Grand View Research,inc.
The global active pharmaceutical ingredients (API) market is
expected to reach a value of USD 239.8 billion by 2025, based on a new report
by Grand View Research, Inc. The rising prevalence of lifestyle-induced &
age-related diseases and cancer is projected to drive the market over the
forecast period. Advancements in recombinant molecular technologies and high
capitalization for development of novel drugs are also estimated to boost
growth.
Favorable government initiatives
for increasing focus toward generic drugs is a key factor for market growth.
Decrease in generic drug prices, higher acceptance in low income and decrease
in reimbursement for branded drugs are the recent trends in the market
affirming growth of generic drugs.
Browse full research report on Active Pharmaceutical
Ingredients Market: http://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market
Further Key Findings from
the Study Suggest:
- Synthetic APIs was the largest segment by revenue
share in 2015 owing to high demand.
- Biotech APIs are estimated to grow lucratively over the
forecast period with high R&D initiatives being undertaken for their
development
- Captive manufacturers, being the conventional option
of API manufacturing, held the majority of the share.
- On the other hand, the merchant manufacturers segment
is expected to be fastest-growing due to growing outsourcing activities
- Generic APIs will experience lucrative growth over
the forecast period attributed to patent expirations of branded drugs
- APIs are identified to have highest application in
cardiovascular therapeutics. Increasing mortality caused by heart diseases
and growing demand for fast-acting drugs are the major factors
contributing to dominance
- North America dominated in terms of revenue share in
2015 and Asia Pacific is expected to grow at a significant growth rate
over the forecast period
- Some of the major companies in the API market are
AbbVie, Inc., Boehringer Ingelheim GmbH, Cipla, Inc., and Merck & Co.,
Inc.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the API market by type of
synthesis, type of manufacturer, type, applications, and region:
API Type of Synthesis Outlook (Revenue, USD Billion, 2014
- 2025)
- Biotech
- Monoclonal
antibodies
- Recombinant
proteins
- Vaccines
- Synthetic
API Type of Manufacturer Outlook (Revenue, USD Billion,
2014 - 2025)
- Captive
APIs
- Merchant
APIs
API Type Outlook (Revenue, USD Billion, 2014 - 2025)
- Generic
APIs
- Innovative
APIs
API Application Outlook (Revenue, USD Billion, 2014 -
2025)
- Cardiovascular
Disease
- Oncology
- CNS
& Neurological Disorders
- Orthopedic
Disorders
- Endocrinology
- Pulmonology
- Gastrointestinal
Disorders
- Nephrology
- Ophthalmology
API Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- Latin
America
- Mexico
- Brazil
- MEA
- South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting services.
To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
Comments
Post a Comment